Emerging biotechs and their investors are exploring partnerships with drug companies at much earlier stages. Experts at ...

Policy pressure, affordability gaps, and consumer expectations are reshaping how pharma companies think about direct to ...

Firm consolidation, thoughtful staffing, disciplined scope control, and performance accountability can save life sciences ...

Epicrispr Biotechnologies CEO Amber Salzman, Ph.D. offers up four imperatives for industry leaders working to develop tomorrows genetic therapies.

It was the summer of 2007 when Chris Anzalone, Ph.D., got a call from Arrowhead Research Company. At the time, Anzalone was working as CEO of the Bennet Group, a private equity firm in Washington, D.C ...

As biotech companies face decreasing productivity, they need ways to do more with less, and fast. A fresh approach to achieve this is by rethinking how innovation is structured: collaborate early and ...

“THAT WAS A TERRIFYING MOMENT,” reflects Matt Patterson, cofounder, chairman, and CEO of Audentes Therapeutics, a genetic medicines company focused on the adeno-associated virus (AAV). It was the fall ...

In the rapidly evolving landscape of pharmaceutical development, AI promises to revolutionize the entire drug discovery and development process, impacting target discovery, clinical trial design, site ...

Biopharma companies face a long journey with each drug they research, test, and — if all goes right — bring to market. And just as new drug development moves forward in phases, so too should your ...

Conferences and trade shows are great places to learn about your competitive environment, as most companies in the industry usually attend these events; this includes competitors, suppliers, customers ...

The pharmaceutical industry sits on a treasure trove of data, brimming with the potential to revolutionize drug development, enhance patient care, and optimize commercial strategies. Yet, this vast ...

Spinning off a $4 billion biopharma business is no easy task. Integrated functions need to be separated, governance boards created, leadership teams assembled, and corporate headquarters established.